Cathy Dahl, DO
Urogynecology and Reconstructive Pelvic Surgery · Lawrence, KSNPI 1871554998
Payments from drug & device makers
What this record shows
This record is dominated by education: $28,100 of the $32,531 with a category attached, or 86.4%. Intuitive Surgical accounts for 95.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $22,295 and has fallen 98.6% since, to $304 in 2025.
Across 86 payments — averaging $378.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$31K
- Medtronic$341
- Astellas Pharma US Inc$293
- Caldera Medical, Inc$184
- AbbVie$168
- Hologic Sales And Service, LLC$145
- plus $476 from 14 others
What the payments were for
- Travel & lodging$8233%
- Food & beverage$3,60711%
- Education$28,10086%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $30,923 |
| Medtronic(2 entities) | 8 | $341 |
| Astellas Pharma US Inc | 13 | $293 |
| Caldera Medical, Inc | 3 | $184 |
| AbbVie(2 entities) | 10 | $168 |
| Hologic Sales And Service, LLC | 8 | $145 |
| Boston Scientific | 3 | $108 |
| Axonics, Inc. | 5 | $89 |
| Merck | 2 | $36 |
| Mayne Pharma Commercial LLC | 3 | $36 |
| Valencia Technologies Corporation | 1 | $32 |
| Urovant Sciences Inc | 2 | $27 |
| Pfizer | 2 | $26 |
| Exact Sciences | 1 | $23 |
| Biogen | 1 | $23 |
| Dentsply IH AB | 1 | $18 |
| Davol Inc. | 1 | $18 |
| 180 Medical, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $13 |
| Smith+Nephew | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$30,904
- Desara$126
- INTERSTIM$125
- INTERSTIM ICON$120
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 93 | $66,655 |
| GemtesaVibegron | 26 | $15,667 |
| BotoxOnabotulinumtoxina | 20 | $13,031 |
| Estradiol | 90 | $5,403 |
| Trospium Chloride ErTrospium Chloride | 18 | $4,034 |
| Solifenacin Succinate | 123 | $3,462 |
| Darifenacin ErDarifenacin Hydrobromide | 16 | $3,216 |
| Methenamine Hippurate | 27 | $1,903 |
| Trospium Chloride | 33 | $1,159 |
| Cephalexin | 97 | $983 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $176 |
| Gabapentin | 72 | $131 |
| Oxycodone Hcl | 41 | $101 |
| Ciprofloxacin Hcl | 19 | $76 |
| Tramadol Hcl | 52 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $293 | $66,65593 claims |
| AbbVieBotox | $168 | $13,03120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few urogynecology and reconstructive pelvic surgery providers in Kansason file to place this against a meaningful peer group, so we don't.
Other urogynecology and reconstructive pelvic surgery in Lawrence
- Charles ButrickOverland Park$97K
- Erika HunterOverland Park$30K
- Patrick NostiOverland Park$6K
- Trang PhamWichita$4K
- Abby StorkOverland Park$2K
- Simon PattonWichita$1K
- Leslie PageWichita$111
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.